BioCentury
ARTICLE | Company News

Baxter Healthcare Corp. blood products/substitutes news

September 21, 1998 7:00 AM UTC

Baxter discontinued all development of its HemAssist crosslinked hemoglobin blood substitute and will focus development efforts on second-generation genetically engineered hemoglobin molecules being d...